Table 1 Patients’ characteristics.

From: Genetic variations in the PI3K-PTEN-AKT-mTOR pathway are associated with distant metastasis in nasopharyngeal carcinoma patients treated with intensity-modulated radiation therapy

Covariate

n = 496(%)

Alive or death

 alive

451 (90.9)

 death

45 (9.1)

Distant Metastasis

 no

422 (85.1)

 yes

74 (14.9)

Gender

 male

321 (64.7)

 female

175 (35.3)

Age (years)

 ≤45

230 (46.4)

 >45

266 (53.6)

T classification

 T1

126 (25.4)

 T2

81 (16.3)

 T3

118 (23.8)

 T4

171 (34.5)

N classification

 N0

51 (10.3)

 N1

234 (47.2)

 N2

147 (29.6)

 N3

64 (12.9)

Clinical Stage

 Stage I

24 (4.8)

 Stage II

101 (20.4)

 Stage III

159 (32.1)

 Stage IV

212 (47.2)

Treatment Modality

 chemoradiotherapy

467 (94.2)

 radiotherapy alone

29 (5.8)

Total Cycles Of Chemotherapy

 ≤3

188 (37.9)

 >3

308 (62.1)